Multiple Ascending Doses (MAD) of Anti-A Disintegrin and Metalloproteinase With Thrombospondin Motifs-5 (Anti-ADAMTS-5) Nanobody in Participants With Knee Osteoarthritis (OA)
Clinical trial NCT03583346 · COMPLETED
Trial details
- NCT number
- NCT03583346
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-23
- Primary completion
- 2019-07-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.